KOSDAQ · Healthcare · ₩116B
₩2,165-1.37%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 1.4% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“비임상 사업이 실적을 받치며 치료제 재개를 준비하는 분기예요.”
In the company's words · 2026 2분기 filing